Autoinjector Device Assessment Study - BCB119

Study identifier:D5554C00001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Evaluation of the Single-Use Pre-Filled Autoinjector

Medical condition

Healthy subjects

Phase

Phase 1

Healthy volunteers

Yes

Study drug

Auto-injector with exenatide suspension, Syringe with exenatide suspension, Syringe with exenatide suspension, Syringe with exenatide suspension, Syringe with exenatide suspension

Sex

All

Actual enrollment

3052

Study type

Interventional

Age

18 Years - 100 Years

Date

Study Start Date: 01 Feb 2013
Primary Completion Date: 01 Dec 2013
Study Completion Date: 01 Dec 2013

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Jan 2015 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

Celerion, Inc

Inclusion and exclusion criteria